Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance
- PMID: 28414465
- DOI: 10.1021/acs.jmedchem.6b01873
Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance
Abstract
The role of the G-protein-coupled bile acid receptor TGR5 in various organs, tissues, and cell types, specifically in intestinal endocrine L-cells and brown adipose tissue, has made it a promising therapeutical target in several diseases, especially type-2 diabetes and metabolic syndrome. However, recent studies have shown deleterious on-target effects of systemic TGR5 agonists. To avoid these systemic effects while stimulating glucagon-like peptide-1 (GLP-1) secreting enteroendocrine L-cells, we have designed TGR5 agonists with low intestinal permeability. In this article, we describe their synthesis, characterization, and biological evaluation. Among them, compound 24 is a potent GLP-1 secretagogue, has low effect on gallbladder volume, and improves glucose homeostasis in a preclinical murine model of diet-induced obesity and insulin resistance, making the proof of concept of the potential of topical intestinal TGR5 agonists as therapeutic agents in type-2 diabetes.
Similar articles
-
Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice.Am J Physiol Gastrointest Liver Physiol. 2019 Mar 1;316(3):G412-G424. doi: 10.1152/ajpgi.00300.2018. Epub 2019 Jan 3. Am J Physiol Gastrointest Liver Physiol. 2019. PMID: 30605011 Free PMC article.
-
Evaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetes.Bioorg Med Chem Lett. 2018 Jun 1;28(10):1849-1852. doi: 10.1016/j.bmcl.2018.04.011. Epub 2018 Apr 5. Bioorg Med Chem Lett. 2018. PMID: 29655980
-
Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus : Focus on Bile Acid Sequestrants.Clin Drug Investig. 2012 Jan;32(1):1-14. doi: 10.2165/11595370-000000000-00000. Clin Drug Investig. 2012. PMID: 27933595 Review.
-
Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.J Biol Chem. 2016 Mar 25;291(13):6626-40. doi: 10.1074/jbc.M115.699504. Epub 2016 Jan 12. J Biol Chem. 2016. PMID: 26757816 Free PMC article.
-
Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes?Am J Physiol Endocrinol Metab. 2010 Jul;299(1):E10-3. doi: 10.1152/ajpendo.00137.2010. Epub 2010 Apr 27. Am J Physiol Endocrinol Metab. 2010. PMID: 20424139 Review.
Cited by
-
Bile acids and coronavirus disease 2019.Acta Pharm Sin B. 2024 May;14(5):1939-1950. doi: 10.1016/j.apsb.2024.02.011. Epub 2024 Feb 13. Acta Pharm Sin B. 2024. PMID: 38799626 Free PMC article. Review.
-
Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets.Signal Transduct Target Ther. 2024 Apr 26;9(1):97. doi: 10.1038/s41392-024-01811-6. Signal Transduct Target Ther. 2024. PMID: 38664391 Free PMC article. Review.
-
Design, Synthesis, Computational and Biological Evaluation of Novel Structure Fragments Based on Lithocholic Acid (LCA).Molecules. 2023 Jul 11;28(14):5332. doi: 10.3390/molecules28145332. Molecules. 2023. PMID: 37513205 Free PMC article.
-
The 16α-hydroxylated Bile Acid, Pythocholic Acid Decreases Food Intake and Increases Oleoylethanolamide in Male Mice.Endocrinology. 2023 Aug 1;164(9):bqad116. doi: 10.1210/endocr/bqad116. Endocrinology. 2023. PMID: 37490843 Free PMC article.
-
N-Arylation of 3-Formylquinolin-2(1H)-ones Using Copper(II)-Catalyzed Chan-Lam Coupling.Molecules. 2022 Nov 30;27(23):8345. doi: 10.3390/molecules27238345. Molecules. 2022. PMID: 36500438 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Medical
